EP1363 - ECE_3272 - Central adiposity drives persistent MASLD risk in postmenopausal women with a phenotype of Polycystic Ovary Syndrome
Polycystic ovary syndrome (PCOS) is increasingly recognised as a lifelong endocrine–metabolic condition, yet its contribution to metabolic dysfunction–associated steatotic liver disease (MASLD) beyond the reproductive years remains uncertain. Menopause is accompanied by adverse changes in fat distribution and met...